Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.

Department of Pharmacology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka 545-8585, Japan.
Circulation (Impact Factor: 14.95). 01/2004; 108(22):2812-8. DOI: 10.1161/01.CIR.0000096486.01652.FC
Source: PubMed

ABSTRACT Apoptosis signal-regulating kinase 1 (ASK1), recently identified as one of the mitogen-activated protein kinase kinase kinases, is activated by various extracellular stimuli and involved in a variety of cellular function. Therefore, we first examined the role of ASK1 in vascular remodeling.
We used rat balloon injury model and cultured vascular smooth muscle cells (VSMCs). Arterial ASK1 activity was rapidly and dramatically increased after balloon injury. To specifically inhibit endogenous ASK1 activation, dominant-negative mutant of ASK1 (DN-ASK1) was transfected into rat carotid artery before balloon injury. Gene transfer of DN-ASK1 significantly prevented neointimal formation at 14 days after injury. Bromodeoxyuridine labeling index at 7 days after injury showed that DN-ASK1 remarkably suppressed VSMC proliferation in both the intima and the media. We also examined the role of ASK1 in cultured rat VSMCs. Infection with DN-ASK1 significantly attenuated serum-induced VSMC proliferation and migration. We also compared neointimal formation after cuff placement around the femoral artery between mice deficient in ASK1 (ASK1-/- mice) and wild-type (WT) mice. Neointimal formation at 28 days after cuff injury in ASK1-/- mice was significantly attenuated compared with WT mice. Furthermore, we compared the proliferation and migration of VSMCs isolated from ASK1-/- mice with WT mice. Both proliferation and migration of VSMCs from ASK1-/- mice were significantly attenuated compared with VSMCs from WT mice.
ASK1 activation plays the key role in vascular intimal hyperplasia. ASK1 may provide the basis for the development of new therapeutic strategy for vascular diseases.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Inflammation is a process essential for host defense and tissue repair. However, excessive inflammation (excessive and/or prolonged production and effects of pro-inflammatory cytokines) may cause pathogenic changes leading to vascular diseases such as rheumatoid arthritis and atherosclerosis. Since inflammatory mediators primarily target vascular endothelial cells (EC), one therapeutic approach to control inflammation is to block specific cytokine signaling in EC. This strategy works in some disease settings but has failed in others. Therefore, anti-TNF therapy targeting both TNFR1 and TNFR2 has been successful in treating rheumatoid arthritis but has failed in the treatment of the cardiovascular diseases. This is because TNF utilizes TNFR1 and TNFR2 to induce different signaling pathways and different EC functions. TNFR1 activates multiple signaling pathways including NF-kB, ASK1-JNK and apoptosis, which can be also activated by other inflammatory stimuli such as endoplasmic reticulum stress. These pathways have been linked to inflammation and EC dysfunction. While NF-kB activates cell survival, ASK1-JNK induces apoptosis. Therefore, inhibition of ASK1-JNK without disruption of cell survival signaling may provide a new strategy for anti-inflammatory therapy. Studies suggest that activation of ASK1-JNK signaling is mediated by a unique AIP1 complex, which is structurally and functionally distinct from the NF-kB-activating complex I. Moreover, AIP1 inhibits the formation of the NF-kB-activating complex I while facilitating the formation of the ASK1-JNK-activating signalosome. Therefore, inhibition of the AIP1-ASK1-JNK pathway may provide a potential anti-inflammatory strategy. In contrast to TNFR1 signaling, much less is known for TNFR2-mediated signaling events. Our data suggest that TNFR2 signaling plays a beneficial role in the cardiovascular system, in part, by activating Bmx and TRAF2-dependent angiogenic and survival pathways. Therefore, specific inhibition of TNFR1 pathways without disruption of TNFR2 signaling may provide new therapeutic opportunities for the treatment of cardiovascular diseases.
    09/2010: pages 137-159;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chondrosarcoma is the primary malignancy of bone that is characterized by a potent capacity to invade locally and cause distant metastasis, and is therefore associated with poor prognoses. Chondrosarcoma further shows a predilection for metastasis to the lungs. The brain-derived neurotrophic factor (BDNF) is a small molecule in the neurotrophin family of growth factors that is associated with the disease status and outcome of cancers. However, the effect of BDNF on cell motility in human chondrosarcoma cells is mostly unknown. Here, we found that human chondrosarcoma cell lines had significantly higher cell motility and BDNF expression compared to normal chondrocytes. We also found that BDNF increased cell motility and expression of matrix metalloproteinase-1 (MMP-1) in human chondrosarcoma cells. BDNF-mediated cell motility and MMP-1 up-regulation were attenuated by Trk inhibitor (K252a), ASK1 inhibitor (thioredoxin), JNK inhibitor (SP600125), and p38 inhibitor (SB203580). Furthermore, BDNF also promoted Sp1 activation. Our results indicate that BDNF enhances the migration and invasion activity of chondrosarcoma cells by increasing MMP-1 expression through a signal transduction pathway that involves the TrkB receptor, ASK1, JNK/p38, and Sp1. BDNF thus represents a promising new target for treating chondrosarcoma metastasis.
    International Journal of Molecular Sciences 01/2013; 14(8):15459-78. · 2.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Apoptosis signal-regulating kinase 1 (ASK1) is a mitogen-activated protein kinase kinase kinase that plays a crucial role in stress-induced apoptosis. Recently, we have reported that suppressed macrophage apoptosis in ASK1 and apolipoprotein E double-knockout mice accelerates atheromatous plaques in the hyperlipidemia-induced atherosclerotic model. However, the pathogenic role of smooth muscle cell (SMC) apoptosis in atherosclerosis still remains unclear. We investigated neointimal remodeling in ligated carotid arteries of ASK1-deficient mice (ASK1(-/-)) for 3 weeks. ASK1(-/-) mice had significantly more suppressed intimal formation, inversely manifesting as potential anti-atherogenic aspects of ASK1 deficiency, characterized by fewer SMCs and less collagen synthesis; and fewer apoptotic SMCs, infiltrating T lymphocytes, and microvessels, associated with decreased apoptosis of luminal endothelial cells, compared with those of wild-type mice. Injured arteries of ASK1(-/-) mice also showed significantly down-regulated expression of pro-apoptotic markers, adhesion molecules, and pro-inflammatory signaling factors. Moreover, tumor necrosis factor-α-induced apoptosis was markedly suppressed in cultured aortic SMCs from ASK1(-/-) mice. These findings suggest that ASK1 accelerates mechanical injury-induced vascular remodeling with activated SMC migration via increased neovascularization and/or enhanced SMC and endothelial cell apoptosis. ASK1 expression, especially in the SMCs, might be crucial, and reciprocally responsible for various pro-atherogenic functions, and SMC apoptosis seems to be detrimental in this model.
    American Journal Of Pathology 11/2012; · 4.60 Impact Factor


Available from

Similar Publications